AN2 Therapeutics, Inc. (ANTX) has a market capitalization of $81.66M and trades at $2.98. The 52-week range is 1-6.91.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.6, Earnings Per Share (EPS) of $-1.16.
The stock has a beta of -1.32, operates in the Healthcare sector.
